Clinical trials: Continuous Ambulatory Peritoneal Dialysis
Children on Chronic Peritoneal Dialysis
Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings
This study aims to compare modified CAPD (M-CAPD) and conventional CAPD (C-CAPD) in terms of delivering high-quality, goal-directed PD as well as avoiding resource wastage in prevalent ESKD patients aged 2 to ≤18 years using a…
- Trial name
- NCT07134595
- Testing
- C-CAPD Prescription, M-CAPD Prescription
- Where
- Philippines
- Volunteers
- 44 people
- Sponsor
- National University Health System, Singapore
End Stage Renal Disease
Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2
The investigators' overarching goal is to improve long-term outcomes for end stage renal disease (ESRD) patients. In this study we focus specifically on patients receiving peritoneal dialysis (PD).
- Trial name
- NCT02212327
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University Medical Center
Renal Function Disorder
Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
This is a multicentre study examining the effectiveness of angiotension converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) or a combination of both in reducing the rate of decline in residual renal function…
- Trial name
- NCT00721773
- Testing
- Benazepril, Valsartan, Benazepril+Valsartan
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Sun Yat-sen University
Renal Failure Chronic
Randomized Controlled Trial on 3D Printed Assistive Device for Continuous Ambulatory Peritoneal Dialysis
Touch contamination during bag exchange in Continuous Ambulatory Peritoneal Dialysis (CAPD) is a common cause of CAPD-related peritonitis.
- Trial name
- NCT05521425
- Testing
- "Helping Hands" for CAPD bag exchange procedures
- Where
- Hong Kong
- Volunteers
- 40 people
- Sponsor
- Queen Elizabeth Hospital, Hong Kong
Hyperuricemia
Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients
The investigators will enroll continuous ambulatory peritoneal dialysis (CAPD) patients with hyperuricemia and randomly divide them into two groups, treated with Febuxostat and placebo respectively.
- Trial name
- LUMINA (NCT03200210)
- Testing
- Febuxostat
- Where
- China
- Volunteers
- 548 people
- Sponsor
- Sun Yat-sen University
Continuous Ambulatory Peritoneal Dialysis
Biomarker for Peritoneal Ultrafiltration Failure
This study will examine the peritoneal tissue, serum and dialysate proteins of peritoneal dialysis (PD) patients with different types of peritoneal solute transport by differential proteomics techniques.
- Trial name
- NCT00728806
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Sun Yat-sen University
End Stage Renal Disease (ESRD), Diabetes
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
Primary Objective: To demonstrate that use of glucose sparing prescriptions, Dianeal, Extraneal, Nutrineal (D-E-N) versus Dianeal only, in diabetic (Type 1 and Type 2) Continuous Ambulatory Peritoneal Dialysis (CAPD) patients…
- Conditions
- End Stage Renal Disease (ESRD), Diabetes, CAPD
- Trial name
- EDEN (NCT01219959)
- Testing
- Dianeal, Dianeal, Extraneal, Nutrineal
- Where
- 16 sites in Colombia
- Volunteers
- 71 people
- Sponsor
- Vantive Health LLC
Peritoneal Dialysis, Continuous Ambulatory
Continuous Ambulatory Peritoneal Dialysis With Telemedicine
This clinical trial is an open-label, prospective, single-arm, single center study. In this study is planned to involve 12 patients, who need continuous ambulatory peritonealis dialysis (CAPD).
- Trial name
- NCT04427514
- Testing
- Telemedicine software for data transmission and analysis in CAPD.
- Volunteers
- 12 people
- Sponsor
- Szeged University
Peritoneal Dialysis, Peritoneal Dialysis, Continuous Ambulatory
The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients
Hypothesis: Intraperitoneal tPA and DNase is well tolerated at a number of different doses. Different doses of tPA and DNase will have a dose-related effect on inflammatory markers (CRP and intraperitoneal white cell count).
- Trial name
- NCT01478698
- Testing
- Tissue Plasminogen Activator (tPA), recombinant deoxyribonuclease (DNase)
- Where
- Australia
- Volunteers
- 5 people
- Sponsor
- Sir Charles Gairdner Hospital
Kidney Failure, Chronic, Peritoneal Dialysis-associated Peritonitis
Prevention of Peritonitis in Peritoneal Dialysis
BACKGROUND: Peritonitis remains a significant problem in peritoneal dialysis (PD). It is the leading cause of technique failure, and contributes to mortality. The incidence is highest during the first year of treatment.
- Conditions
- Kidney Failure, Chronic, Peritoneal Dialysis-associated Peritonitis, Dialysis Capd Infection
- Trial name
- PEPS (NCT01293799)
- Testing
- Retraining
- Where
- Sweden
- Volunteers
- 713 people
- Sponsor
- Sahlgrenska University Hospital
Chronic Renal Failure
Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.
Apart from haemodialysis, continuous ambulatory peritoneal dialysis (CAPD) is another effective therapy for end stage renal disease (ESRD).
- Trial name
- NCT00255619
- Testing
- Baxter's UltraBag® and FMC Andy·Disc®
- Where
- 6 sites in Malaysia
- Volunteers
- 264 people
- Sponsor
- Ministry of Health, Malaysia
End-Stage Renal Disease
Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)
This study is to examine the safety of daptomycin in patients with End Stage Renal Disease.
- Trial name
- NCT00490737
- Testing
- daptomycin
- Volunteers
- 12 people
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
End Stage Renal Disease, Diabetes
Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
The current study is initiated in order to assess the impact of a PD solution containing L-carnitine on insulin sensitivity evaluated by measuring insulin requirement.
- Trial name
- NCT00755404
- Testing
- PD Solution, PD solution containing L-carnitine
- Where
- 8 sites in Italy
- Sponsor
- Iperboreal Pharma Srl
End Stage Renal Disease
Cost Utility Analysis of HD and CAPD in Ministry of Health Dialysis Centres, Malaysia
End-stage renal disease represents a major problem for public health, and is a severe disease affecting hundreds of millions of people in the world and increasing rapidly.
- Trial name
- NCT02862717
- Where
- 5 sites in Malaysia
- Volunteers
- 173 people
- Sponsor
- National University of Malaysia
End-Stage Kidney Disease, Peritoneal Dialysis
Nocturnal APD vs. CAPD in Non-diabetic ESKD
Background: Continuous ambulatory peritoneal dialysis (CAPD) imposes a substantial daytime burden. Nocturnal automated peritoneal dialysis (APD) may improve patient-centered outcomes, but high-quality evidence is lacking.
- Trial name
- NCT05449067
- Testing
- Nocturnal automated peritoneal dialysis (APD), Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Where
- China
- Volunteers
- 137 people
- Sponsor
- Nanfang Hospital, Southern Medical University
End-Stage Kidney Disease (ESKD), Hemodialysis
Cardiovascular and Bone Mineral Markers in Dialysis Patients and Healthy Controls
This observational study will compare cardiovascular status, bone mineral metabolism, systemic inflammation, body composition, functional status, quality of life, pruritus, and pain among patients receiving different renal…
- Conditions
- End-Stage Kidney Disease (ESKD), Hemodialysis, Peritoneal Dialysis (PD)
- Trial name
- NCT07686978
- Where
- Turkey (Türkiye)
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Gazi University
End-Stage Renal Disease
Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
A major challenge of peritoneal dialysis (PD) therapy is the development of glucose-sparing strategies able to provide an efficacious ultrafiltration (UF) profile.
- Trial name
- NCT00858182
- Testing
- PD solution for nocturnal exchanges, PD solution for diurnal exchanges
- Sponsor
- Iperboreal Pharma Srl
Peritonitis
Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients
To compare the efficacy of single versus combined antibiotic therapy for bacterial peritonitis in CAPD patients.
- Trial name
- NCT01785641
- Testing
- ceftazidime+ciprofloxacin, ceftazidime monotherapy, cefazolin+gentamicin
- Where
- Thailand
- Volunteers
- 300 people
- Sponsor
- Chulalongkorn University
Continuous Ambulatory Peritoneal Dialysis
The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
A prospective, randomized, open-label, Single-center clinical trial to determine whether Enalapril or Enalapril plus Losartan effect on Peritoneal membrane transportation.
- Trial name
- NCT01041963
- Testing
- Enalapril, Enalapril plus Losartan
- Where
- Thailand
- Volunteers
- 90 people
- Sponsor
- Chulalongkorn University
Chronic Kidney Failure
Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
The aim of this study is to assess the superiority of the new low sodium peritoneal dialysis (PD) solution PDsol 12 in comparison with a conventional, already marketed solution, Gambrosol trio 40, in the treatment of the…
- Trial name
- PDOne (NCT00794326)
- Testing
- Solution for Peritoneal Dialysis
- Where
- 29 sites in Denmark, France and 3 more
- Volunteers
- 140 people
- Sponsor
- Fresenius Medical Care Deutschland GmbH